This muscle-to-kidney pathway is a recognized risk in distance athletes, outdoor workers, and military personnel
Product Name: Tirzepatide Classification: Dual GIP/GLP-1 Receptor Agonist Structural Description: 39-amino acid dual GIP/GLP-1 receptor agonist CAS Number: 2023788-19-2 Molecular Weight: 4813.45 g/mol Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: Lyophilized (freeze-dried) powder Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
It works most effectively when used in conjunction with a diabetes-friendly diet and regular exercise
Synthesis Somalutide side chain is synthesized from tetradecanedioic acid by condensation, reduction, ring-opening and Boc monoprotection of first synthesizing the intermediate mono-tert-butyl octadecanedioate, and then by further condensation reaction of the intermediate
[12] [1] Liu J, Head E, Kuratsune H, Cotman CW, Ames BN
1 g each labeled cRNA was fragmented by adding 11 l 10X blocking agent (Takara Bio, Inc., Shiga, Japan and 2.2 l 25X fragmentation buffer (Takara Bio, Inc.), then heated at 60C for 30 min